Metagenomi, Inc. Common Stock

Entry into a Material Definitive Agreement. On September 29, 2025 (the “Effective Date”), Metagenomi, Inc. (the “Company”) entered into a Non-Exclusive License

Termination of a Material Definitive Agreement. On September 30, 2025 (the “Termination Date”), the Company delivered to Affini-T Therapeutics, Inc. (“Affini-T”